Literature DB >> 3457100

Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.

D H Miller, R W Hornabrook, J Dagger, R Fong.   

Abstract

A recent survey revealed 237 cases of multiple sclerosis in Wellington, New Zealand, giving an overall prevalence of 69 cases per 100,000. Two hundred and thirty-five were European with one Asian and only one Maori, confirming the rarity of the disease in Maoris. HLA A3, B7 and DR2 antigens were more frequent in multiple sclerosis patients compared with European controls. The same antigens were much less common in the Maori population. The results suggest that Maoris have a low susceptibility to multiple sclerosis despite living in a high risk area, and that genetic susceptibility may be related to the HLA system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3457100      PMCID: PMC1028646          DOI: 10.1136/jnnp.49.1.43

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Multiple sclerosis and amyotrophic lateral sclerosis; etiologic significance of recent epidemiologic and genetic studies.

Authors:  L T KURLAND; D W MULDER; K B WESTLUND
Journal:  N Engl J Med       Date:  1955-04-21       Impact factor: 91.245

2.  The prevalence of multiple sclerosis in Australia.

Authors:  J M SUTHERLAND; J H TYRER; M J EADIE
Journal:  Brain       Date:  1962-03       Impact factor: 13.501

Review 3.  The significance of the association between HLA and multiple sclerosis.

Authors:  J R Batchelor; A Compston; W I McDonald
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

4.  On the risk of multiple sclerosis according to age at immigration to South Africa.

Authors:  G Dean; J F Kurtzke
Journal:  Br Med J       Date:  1971-09-25

5.  Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart.

Authors:  M G McCall; T L Brereton; A Dawson; K Millingen; J M Sutherland; E D Acheson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-02       Impact factor: 10.154

Review 6.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

7.  HLA family studies and multiple sclerosis: A common gene, dominantly expressed.

Authors:  G J Stewart; J G McLeod; A Basten; H V Bashir
Journal:  Hum Immunol       Date:  1981-08       Impact factor: 2.850

8.  Multiple sclerosis in twins.

Authors:  A Williams; R Eldridge; H McFarland; S Houff; H Krebs; D McFarlin
Journal:  Neurology       Date:  1980-11       Impact factor: 9.910

9.  HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees.

Authors:  J L Tiwari; S E Hodge; P I Terasaki; M A Spence
Journal:  Am J Hum Genet       Date:  1980-01       Impact factor: 11.025

10.  Multiple sclerosis: the present position.

Authors:  W I McDonald
Journal:  Acta Neurol Scand       Date:  1983-08       Impact factor: 3.209

View more
  6 in total

1.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?

Authors:  D H Miller; S R Hammond; J G McLeod; G Purdie; D C Skegg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  Risk factors for multiple sclerosis: race or place?

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

3.  Multiple sclerosis: nature or nurture?

Authors:  D C Skegg
Journal:  BMJ       Date:  1991-02-02

4.  Class II HLA antigens in multiple sclerosis.

Authors:  D H Miller; R W Hornabrook; J Dagger; R Fong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

5.  The natural history of multiple sclerosis: a regional study with some longitudinal data.

Authors:  D H Miller; R W Hornabrook; G Purdie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

Review 6.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.